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Background: The aim of this study was to examine the attribution of each cardiovascular risk factor in
combination with abdominal obesity (AO) on Japanese health expenditures.
Methods: The health insurance claims of 43,469 National Health Insurance beneﬁciaries aged 40e75
years in Ibaraki, Japan, from the second cohort of the Ibaraki Prefectural Health Study were followed-up
from 2009 through 2013. Multivariable health expenditure ratios (HERs) of diabetes mellitus (DM), high
low-density lipoprotein cholesterol (LDL-C), low high-density lipoprotein cholesterol (HDL-C), and hy-
pertension with and without AO were calculated with reference to no risk factors using a Tweedie
regression model.
Results: Without AO, HERs were 1.58 for DM, 1.06 for high LDL-C, 1.27 for low HDL-C, and 1.31 for hy-
pertension (all P < 0.05). With AO, HERs were 1.15 for AO, 1.42 for DM, 1.03 for high LDL-C, 1.11 for low
HDL-C, and 1.26 for hypertension (all P < 0.05, except high LDL-C). Without AO, population attributable
fractions (PAFs) were 2.8% for DM, 0.8% for high LDL-C, 0.7% for low HDL-C, and 6.5% for hypertension.
With AO, PAFs were 1.0% for AO, 2.3% for DM, 0.4% for low HDL-C, and 5.0% for hypertension.
Conclusions: Of the obesity-related cardiovascular risk factors, hypertension, independent of AO, appears
to impose the greatest burden on Japanese health expenditures.
© 2017 The Authors. Publishing services by Elsevier B.V. on behalf of The Japan Epidemiological
Association. This is an open access article under the CC BY license (http://creativecommons.org/licenses/
by/4.0/).Introduction
Ratios of total health expenditures to Gross Domestic Product
have been increasing in most Organization for Economic Co-
operation and Development (OECD) countries.1 Many countries
have health care systems that can be divided into three categories:h, Dokkyo Medical University
gun-Mibu, Tochigi 321-0293,
nchi).
demiological Association.
Elsevier B.V. on behalf of The Japa(i) social insurance systems, such as in Japan, France, and Germany;
(ii) tax-based systems, such as in the United Kingdom (UK) and
Sweden; and (iii) limited services to the elderly or disabled in the
United States of America (USA), that is Medicare andMedicaid.2 The
proportion of population coverage reached 100% in 22 of 31 OECD
countries. Moreover, the coverage in the USA is being expanded by
the Affordable Care Act.3
Cardiovascular diseases, such as ischemic heart diseases and
cerebrovascular diseases, result in high mortality in most OECD
countries,1 which can lead to high expenditures. Many previous
studies have shown the associations of abdominal obesity, diabetes
mellitus, high serum total cholesterol levels, low high-densityn Epidemiological Association. This is an open access article under the CC BY license
T. Sairenchi et al. / Journal of Epidemiology 27 (2017) 354e359 355lipoprotein cholesterol (HDL-C) levels, and hypertension, which are
major risk factors for cardiovascular risk factors in terms of obesity
and metabolic syndrome, with health expenditures.4e14 Several
studies have shown that metabolic syndrome per se and abdominal
obesity might not have an important effect on health expenditures
in the USA and Taiwan.4,5
However, to the best of our knowledge, no study has investi-
gated the relationships of each cardiovascular risk factor in com-
bination with abdominal obesity and their effects on health
expenditures. Thus, the aim of the present study was to examine
the impact, as indicated by the health expenditure ratio (HER), and
attribution, as indicated by the population attributable fraction
(PAF), of cardiovascular risk factors, with or without abdominal
obesity, on health expenditures in Japan.
Methods
Health insurance system in Japan
The Japanese government has organized several health insur-
ance schemes,15 and all citizens are obliged to join one. The Na-
tional Health Insurance, one of them, is mainly for farmers, self-
employed persons, retired persons, and their nonworking de-
pendents aged less than 75 years. The Late-Stage Medical Care
System for the Elderly is mainly for persons aged 75 years or more.
Access to medical care is unlimited for all persons. The unit prices
for medical care are decided by the government. Individuals must
pay 10e30% of the medical fees, and the remainder is paid by the
insurance. In the present study, the health expenditures included
the portion of medical expenses paid individually.
Study cohort and population
A total of 90,442 beneﬁciaries aged 40e75 years who completed
a health check-up conducted by 21 of 44 Japanese National Health
Insurance schemes in Ibaraki Prefecture in ﬁscal year 2009 (from
April 2009 to March 2010) were recruited in the second cohort of
the Ibaraki Prefectural Health Study. Written informed consent was
obtained from 58,757 of those beneﬁciaries. However, 5418 in-
dividuals could not be matched with their health check-up data
because of invalid numbering. Thus, the second cohort of the
Ibaraki Prefectural Health Study consisted of 53,339 participants.
The participants' health claim records were followed-up until the
end of ﬁscal year 2013.
In this cohort study, 4550 participants with missing values for
waist circumference, both fasting blood glucose and glyco-
hemoglobin A1c (HbA1c) levels, low-density lipoprotein choles-
terol (LDL-C) levels, HDL-C levels, systolic blood pressure (SBP),
diastolic blood pressure (SBP), age, sex, smoking status, drinking
habits, proteinuria, and/or of the follow-up period were excluded.
Furthermore, 5320 participants with a history of stroke, heart
disease, and/or kidney disease were excluded. Thus, the data of
43,469 participants were analyzed.
Baseline measurements
At baseline, the subjects completed a self-administered lifestyle
questionnaire. The questionnaire included questions about smok-
ing status and drinking habits.
The health check-ups were conducted by the Ibaraki Health
Service Association for the participants in 20 districts and by the
Hitachi Medical Center for the participants in one district. Most
(96%) of the participants underwent the health check-ups by the
Ibaraki Health Service Association.For the check-ups conducted by the Ibaraki Health Service As-
sociation, waist circumferences were measured in light clothing.
SBP and DBP were measured using the right arm of seated subjects
by trained observers using automated sphygmomanometers. Blood
samples were drawn from seated subjects; fasting was not
required. Plasma glucose levels were measured using an enzymatic
method if the subjects were fasting. HbA1c levels were measured
using immunoassay if the subjects were non-fasting or had un-
known fasting status. In this study, the HbA1c levels are shown
according to the National Glycohemoglobin Standardization Pro-
gram. LDL-C levels were measured using an enzymatic method.
Proteinuria levels were tested using a dipstick, and trace positive
samples of proteinuria were re-examined using a sulphosalicylic
acid test. An interview was conducted to ascertain the use of anti-
diabetic medication, anti-dyslipidemic medication, and anti-
hypertension medication, as well as histories of stroke, heart dis-
ease, and kidney disease.
For the check-ups conducted by the Hitachi Medical Center,
HbA1c levels were measured using a high-performance liquid
chromatography method if the subjects were non-fasting or had
unknown fasting status. However, both laboratories participated in
the same quality control programs directed by the Japan Medical
Association, the National Federation of Industrial Health Organi-
zation, and the Ibaraki Association of Medical Technologists. Other
measurement methods were the same as for check-ups conducted
by the Ibaraki Health Service Association.Follow-up surveillance
To ascertain the medical expenditures of the participants,
medical (outpatient and inpatient), dental, and pharmaceutical
health insurance claim records of the participants were obtained
from the Ibaraki National Health Insurance Organization. Moreover,
the dates of acquisition and loss of eligibility of a recipient were
obtained to ascertain the days the participants were eligible re-
cipients. Follow-ups were restarted if the participants who had lost
their eligibility to be recipients re-acquired their eligibility to be
recipients. In addition, the follow-ups were continued even if the
participants changed from the National Health Insurance to the
Late-Stage Medical Care System for the Elderly.Deﬁnitions
Abdominal obesity was deﬁned as waist circumference 85 cm
for men and 90 cm for women, referring to the Japanese deﬁni-
tion of metabolic syndrome.16 Diabetes was deﬁned as fasting blood
glucose 126 mg/dL (7.0 mmol/L), HbA1c  6.5%, or anti-diabetic
medication use according to the guidelines of the World Health
Organization.17,18 High LDL-C was deﬁned as LDL-C  160 mg/dL
(4.1 mmol/L) or anti-dyslipidemic medication use, and lowHDL-C
was deﬁned as HDL-C < 40 mg/dL (<1.0 mmol/L) according to the
executive summary of the Third Report of the National Cholesterol
Education Program Expert Panel on Detection, Evaluation, and
Treatment of High Blood Cholesterol in Adults III.19 Hypertension
was deﬁned as systolic blood pressure (SBP) 140 mm Hg, DBP
90 mm Hg, or anti-hypertensive medication use according to the
2014 Evidence-Based Guideline for the Management of High Blood
Pressure in Adults Report from the Panel Members Appointed to
the Eighth Joint National Committee.20 Smoking habit was divided
into three categories: non-smoker, ex-smoker, and current smoker.
Alcohol intake was divided into seven categories: non-drinker, ex-
drinker, 1e3 days per month, 1e2 days per week, 3e4 days per
week, 5e6 days per week, and every day. Proteinuria was divided
into four categories: , þ, 2þ, and 3þ.
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The unit of health expenditures was set as the Japanese yen (i.e.,
123.9 Japanese yen ¼ 1 USA dollar, at the exchange rates published
on June 17, 2015). The P values for differences in baseline charac-
teristics according to the presence or absence of each risk factor
were calculated using analysis of variance for age, and using c2 tests
for sex, smoking status, drinking habits, and proteinuria.
HERs and 95% conﬁdence interval (CI) according to the presence
or absence of the risk factors were calculated with reference to no
risk factor using a generalized linear model with an assumption of
the Tweedie (compound Poisson-Gamma) distribution, which is
the most widely used method in insurance claims modeling.21 The
link function was logarithmic. The log-transformed years of eligi-
bility to be a recipient were treated as an offset variable. Covariates
included age and sex in the age- and sex-adjusted model. Cova-
riates included age, sex, smoking status, drinking habits, protein-
uria, and the risk factors of interest in the multivariable model. All
statistical tests were 2-sided, and P < 0.05 was regarded as signif-
icant. The statistical analyses were conducted with SAS, version 9.4
(SAS Institute, Inc, Cary, NC, USA). Furthermore, PAFs were calcu-
lated using the following formula:
PAF ¼ pd

mHER 1
mHER

;
where pd is the proportion of expenditures from the group exposed
to the risk factor among total expenditures, and mHER is a multi-
variable HER.22 The 95% conﬁdence intervals of PAF were calculated
using the following formula23:
Q ¼ logð1 PAFÞ;
VarðQÞ ¼ PAF
2
ð1 PAFÞ2
 bV
ðmHER 1Þ2
þ 2
e1ðmHER 1Þ
þ e2
e1ðe2 þ e2Þ
!
;
where bV is a variance estimate for logðmHERÞ, e1 is expenditures
from exposed persons, and e2 is the expenditures from non-
exposed persons.
CIPAF ¼ 1 exp

Q±1:96
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
VarðQÞ
q 
;
where CIPAF is a 95% conﬁdence interval for PAF.
Standard protocol approvals, registrations, and patient consent
Written informed consent was obtained from all individual
participants included in the study. The Ethics Committee of Ibaraki
Prefecture and the Bioethics Committee of Dokkyo Medical Uni-
versity approved this study.
Results
During 209,101 person-years of follow-up for 43,469 partici-
pants, visits to clinics and/or hospitals of 43,169 persons, 3,870,460
claims, and health expenditures of 59,991,370,680 Japanese yen
($484,191,854 USA dollars) were observed. Of the participants, 158
men and 142 women had health expenditures of zero Japanese yen.
The baseline characteristics are shown in Table 1. Mean age and
the proportions of men, smoking status, drinking habits, and pro-
teinuria were signiﬁcantly different according to the presence orabsence of abdominal obesity, diabetes mellitus, high LDL-C, low
HDL-C, and hypertension, excluding proteinuria with high LDL-C.
The HERs and PAFs according to the presence or absence of each
risk factor for the participants are shown in Table 2. Signiﬁcant
associations between each risk factor and health expenditures were
found in the age- and sex-adjusted analyses, as well as in the
multivariable analyses. The highest multivariable HER was for
diabetes mellitus. On the other hand, the highest PAF was observed
for hypertension.
The multivariable HERs and PAFs according to the combination
of risk factors and abdominal obesity are shown in Table 3. Signif-
icantly higher multivariable HERs were observed for all combina-
tions, except for high LDL-C with abdominal obesity. The highest
multivariable HER was observed for diabetes mellitus without
abdominal obesity. The highest PAF was observed for hypertension
without abdominal obesity followed by hypertension with
abdominal obesity.
Discussion
To the best of our knowledge, the present study is the ﬁrst to
show that the obesity-related cardiovascular risk factor related to
the greatest attribution on the Japanese National Health Insurance
expenditures was hypertension, independent of abdominal obesity.
The present results support the importance of the prevention of
hypertension for persons with and without abdominal obesity for
health expenditures in Japan. In addition, metabolic syndrome,
which assumes abdominal obesity to be indispensable, might have
to be treated as one of multiple risk factors from the perspective of
primary prevention for a sustainable health insurance system.
Several studies have investigated the relationships between car-
diovascular risk factors and health expenditures.4e14 The Cardiovas-
cular Health Study5 showed higher costs of 14.9% (95% CI, 4.3%e
26.7%) for abdominal obesity, 15.8% (95% CI,1.7%e31.8%) for low HDL
cholesterol, and 20.4% (95% CI, 10.1%e31.7%) for elevated blood
pressure of the totalMedicare costs. The studyalso showed that there
was no signiﬁcant association between metabolic syndrome and
Medicare costs. The Chicago Heart Association Detection Project in
Industry6 showed an association between high blood pressure (SBP
120 mm Hg or DBP 80 mm Hg) and Medicare costs related to
cardiovascular disease in men and women. In another report of the
Chicago Heart Association Detection Project in Industry,7 the
adjusted average annual total Medicare costs of subjects with body
mass index (BMI)25.0e29.9kg/m2comparedwithBMI18.5e24.9kg/
m2 were 1.12-fold higher in men and 1.20-fold higher in women. A
large prospective cohort study8 showed that the average total
Medicare expenditures of beneﬁciaries with diabetes was approxi-
mately 1.7-fold higher than that of beneﬁciaries without diabetes.
The Elderly Nutrition and Health Survey in Taiwan4 showed
adjusted cost ratios of 1.45 for high fasting glucose (100 mg/dL or
current use of diabetes medication) and 1.46 for high blood pres-
sure (SPB 130 mm Hg, DBP 85 mm Hg, or current use of anti-
hypertensive medication) in men, whereas central obesity (waist
circumference 90 cm for men or 80 cm for women) was not
signiﬁcant. The Ohsaki Study9 showed that the total medical costs
of participants with BMI 25.0e29.9 kg/m2 and with BMI 30.0 kg/
m2 were approximately 1.1- and 1.2-fold higher, respectively, than
participants with BMI 21.0e22.9 kg/m2, and the excess direct costs
attributable to BMI 25.0 kg/m2 were 3.2% of total health care
expenditures. The subgroup analysis of the Ohsaki Study13 indi-
cated that the excess adjusted total cost was 9.4% for overweight/
obesity (BMI 25 kg/m2), 35.6% for hypertension (SBP
140 mm Hg, DBP 90 mm Hg, or antihypertensive medication
use), 42.2% for hyperglycemia (casual plasma glucose 150 mg/dL
or history of diabetes), and no excess cost for dyslipidemia (serum
Table 1
Baseline characteristics according to absence or presence of cardiovascular risk factors among 43,469 Japanese National Health Insurance beneﬁciaries aged 40e74 years in Ibaraki, Japan, 2009.
Abdominal obesity P for
differencea
Diabetes mellitus P for
differencea
High LDL-C P for
differencea
Low HDL-C P for
differencea
Hypertension P for
differencea
Absence Presence Absence Presence Absence Presence Absence Presence Absence Presence
Number of
participants
29,383 14,086 39,345 4124 33,681 9788 40,804 2665 25,645 17,824
Age, years, mean
(SD)
62.9 (8.2) 63.7 (8.2) <0.001 62.9 (8.3) 65.5 (6.5) <0.001 62.8 (8.5) 64.5 (7.0) <0.001 63.1 (8.2) 64.0 (8.5) <0.001 61.4 (8.8) 65.7 (6.6) <0.001
Male, n (%) 9633 (32.8) 9188 (65.2) <0.001 16,398 (41.7) 2423 (58.8) <0.001 15,977 (47.4) 2844 (29.1) <0.001 16,833 (41.3) 1988 (74.6) <0.001 10,279 (40.1) 8542 (47.9) <0.001
Smoking status,
n (%)
<0.001 <0.001 <0.001 <0.001 <0.001
Non-smoker 23,009 (78.3) 9491 (67.4) 29,624 (75.3) 2876 (69.7) 24,493 (72.7) 8007 (81.8) 30,968 (75.9) 1532 (57.5) 18,833 (73.4) 13,667 (76.7)
Ex-smoker 2346 (8.0) 1806 (12.8) 3666 (9.3) 486 (11.8) 3433 (10.2) 719 (7.3) 3834 (9.4) 318 (11.9) 2407 (9.4) 1745 (9.8)
Current smoker 4028 (13.7) 2789 (19.8) 6055 (15.4) 762 (18.5) 5755 (17.1) 1062 (10.9) 6002 (14.7) 815 (30.6) 4405 (17.2) 2412 (13.5)
Drinking habits,
n (%)
<0.001 <0.001 <0.001 <0.001 <0.001
Non-drinker 16,417 (55.9) 5765 (40.9) 20,181 (51.3) 2001 (48.5) 16,104 (47.8) 6078 (62.1) 20,823 (51.0) 1359 (51.0) 13,767 (53.7) 8415 (47.2)
Ex-drinker 468 (1.6) 326 (2.3) 656 (1.7) 138 (3.3) 648 (1.9) 146 (1.5) 668 (1.6) 126 (4.7) 476 (1.9) 318 (1.8)
1e3 days
per month
2405 (8.2) 1044 (7.4) 3089 (7.9) 360 (8.7) 2615 (7.8) 834 (8.5) 3182 (7.8) 267 (10.0) 2222 (8.7) 1227 (6.9)
1e2 days
per week
2016 (6.9) 993 (7.0) 2740 (7.0) 269 (6.5) 2292 (6.8) 717 (7.3) 2808 (6.9) 201 (7.5) 1873 (7.3) 1136 (6.4)
3e4 days
per week
1806 (6.1) 1060 (7.5) 2605 (6.6) 261 (6.3) 2358 (7.0) 508 (5.2) 2676 (6.6) 190 (7.1) 1665 (6.5) 1201 (6.7)
5e6 days
per week
1835 (6.2) 1266 (9.0) 2803 (7.1) 298 (7.2) 2618 (7.8) 483 (4.9) 2939 (7.2) 162 (6.1) 1657 (6.5) 1444 (8.1)
Everyday 4436 (15.1) 3632 (25.8) 7271 (18.5) 797 (19.3) 7046 (20.9) 1022 (10.4) 7708 (18.9) 360 (13.5) 3985 (15.5) 4083 (22.9)
Proteinuria,
n (%)
0.077 <0.001
28,976 (98.6) 13,588 (96.5) 38,745 (98.5) 3819 (92.6) 33,012 (98.0) 9552 (97.6) 40,009 (98.1) 2555 (95.9) 25,403 (99.1) 17,161 (96.3)
þ 301 (1.0) 343 (2.4) 442 (1.1) 202 (4.9) 474 (1.4) 170 (1.7) 572 (1.4) 72 (2.7) 183 (0.7) 461 (2.6)
2þ 82 (0.3) 120 (0.9) 128 (0.3) 74 (1.8) 151 (0.4) 51 (0.5) 173 (0.4) 29 (1.1) 50 (0.2) 152 (0.9)
3þ 24 (0.1) 35 (0.2) 30 (0.1) 29 (0.7) 44 (0.1) 15 (0.2) 50 (0.1) 9 (0.3) 9 (0.0) 50 (0.3)
LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; SD, standard deviation.
a Tested by analysis of variance for age and a chi-square test for other variables.
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Table 2
Health expenditure ratios and population attributable fractions according to the presence or absence of each risk factor among 43,469 Japanese National Health Insurance
beneﬁciaries aged 40e74 years in Ibaraki, Japan, 2009e2013.
Risk factors at
baseline
Number of
participants
Person-years Health expenditures per
person-year, JPY (USD)
Sex- and age-adjusted health
expenditure ratioa (95% CI)
Multivariable health
expenditure ratiob (95% CI)
Population attributable
fraction (%) (95% CI)
No risk 14,258 68,031 200,297 (1617) e 1 (ref)
Abdominal obesity 14,086 67,789 335,177 (2705) 1.20 (1.17,1.22) 1.10 (1.07,1.12) 3.3 (2.6, 4.0)
Diabetes mellitus 4124 19,825 467,634 (3774) 1.61 (1.57,1.66) 1.50 (1.46,1.55) 5.2 (4.9, 5.5)
High LDL-C 9788 47,355 315,555 (2547) 1.10 (1.07,1.12) 1.05 (1.03,1.07) 1.1 (0.6, 1.6)
Low HDL-C 2665 12,726 376,858 (3042) 1.26 (1.22,1.31) 1.18 (1.14,1.22) 1.2 (1.0, 1.5)
Hypertension 17,824 86,387 362,345 (2924) 1.33 (1.31,1.36) 1.29 (1.27,1.31) 11.7 (11.0, 12.5)
CI, conﬁdence interval; HDL-C, high-density lipoprotein cholesterol; JPY, Japanese yen; LDL-C, low-density lipoprotein cholesterol; USD, United States dollar.
a The reference category was the absence of each risk factor.
b Adjusted for age, sex, smoking status (non-smoker, ex-smoker, and current smoker), drinking habits (non-drinker, ex-drinker, 1e3 days per month, 1e2 days per week,
3e4 days per week, 5e6 days per week, and every day), proteinuria (, þ, 2þ, and 3þ), and risk factors in this table with each other.
Table 3
Multivariable health expenditure ratios and population attributable fractions according to combinations of risk factors and abdominal obesity among 43,469 Japanese National
Health Insurance beneﬁciaries aged 40e74 years in Ibaraki, Japan, 2009e2013.
Risk factors at baseline Number of
participants
Person-years Health expenditures per
person-year, JPY (USD)
Multivariable health
expenditure ratioa (95% CI)
Population attributable
fraction (%) (95% CI)
Without abdominal obesity
No risk 14,258 6,8031 200,297 (1617) 1 (ref) e
Diabetes mellitus 2054 9912 459,062 (3705) 1.58 (1.51,1.64) 2.8 (2.6, 3.0)
High LDL-C 6320 30,637 294,879 (2380) 1.06 (1.03,1.09) 0.8 (0.4, 1.2)
Low HDL-C 1148 5512 368,911 (2977) 1.27 (1.20,1.34) 0.7 (0.6, 0.9)
Hypertension 10,074 48,855 342,034 (2761) 1.31 (1.28,1.34) 6.5 (6.0, 7.0)
With abdominal obesity
No risk
(Only abdominal obesity)
3858 18,460 240,777 (1943) 1.15 (1.11,1.18) 1.0 (0.8, 1.2)
Diabetes mellitus 2070 9913 476,205 (3843) 1.42 (1.36,1.48) 2.3 (2.1, 2.6)
High LDL-C 3468 16,718 353,443 (2853) 1.03 (0.99,1.06) e
Low HDL-C 1517 7214 382,929 (3019) 1.11 (1.05,1.16) 0.4 (0.2, 0.7)
Hypertension 7750 37,532 388,784 (3138) 1.26 (1.22,1.30) 5.0 (4.4, 5.6)
CI, conﬁdence interval; HDL-C, high-density lipoprotein cholesterol; JPY, Japanese yen; LDL-C, low-density lipoprotein cholesterol; USD, United States dollar.
a Adjusted for age, sex, smoking status (non-smoker, ex-smoker, and current smoker), drinking habits (non-drinker, ex-drinker, 1e3 days per month, 1e2 days per week,
3e4 days per week, 5e6 days per week, and every day), proteinuria (, þ, 2þ, and 3þ), and risk factors in this table with each other.
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cholesterol<40mg/dL). The Health Promotion Research Committee
of the Shiga National Health Insurance Organizations12 reported
that subjects with BMI 25.0 kg/m2 had approximately 1.3-fold
higher adjusted geometric mean medical expenditures compared
with those with BMI of 18.5e24.9 kg/m2, and the excess medical
costs attributable to obesity (BMI 25.0 kg/m2) were 3.1% of total
medical costs. The Health Promotion Research Committee of the
Shiga National Health Insurance Organizations10 also showed that
the adjusted geometric mean of beneﬁciaries with Stage 1 hyper-
tension compared to those with normal blood pressure was 1.24-
fold higher for men and 1.01-fold higher for women, and they
also showed that the percentage of stage 1 and 2 hypertension-
related medical costs for the beneﬁciaries was 14.2%. Another
report of the Health Promotion Research Committee of the Shiga
National Health Insurance Organizations11 showed that total
medical expenditure was approximately two-fold higher for sub-
jects with diabetes (history of diabetes) than for those without
diabetes. Furthermore, in another report of the Health Promotion
Research Committee of the Shiga National Health Insurance Orga-
nizations,14 the excess medical expenditures attributable to car-
diovascular risk factors with normal weight were higher than in
those who were overweight (BMI 25.0 kg/m2). Those previous
studies suggested that each cardiovascular risk factor (i.e., obesity,
hyperglycemia, dyslipidemia, and high blood pressures) was asso-
ciated with health expenditures, as in the present study. However,
those previous studies did not investigate the association of each
cardiovascular risk factor with health expenditures in combination
with abdominal obesity.The strength of the present study was the statistical analysis
with a Tweedie distribution, which is themost widely usedmixture
distribution model in insurance claims modeling. The Tweedie
distribution is deﬁned as a Poisson sum of gamma random vari-
ables, known as an aggregate loss in actuarial science.21 The
Tweedie model is a generalized linear model from the exponential
family. A Tweedie random variable can be represented as a Poisson
sum of gamma distributed random variables. That is,
Y ¼
XN
i¼1
Yi
where N has a Poisson distribution, and Yi s have independent,
identical gamma distributions. In this case, Y has a discrete mass at
0, PrðY ¼ 0Þ ¼ PrðN ¼ 0Þ ¼ expðlÞ, where l is the mean of Poisson
distribution, and the probability density of Y f ðyÞ is represented by
an inﬁnite series fory>0.24 That is, a Tweedie distribution can treat
a gamma distribution with inﬂated zero data, such as health claim
data, simultaneously. In Tweedie distributions, a compound
Poisson-Gamma distribution is produced when the power param-
eter p is >1 and <2. In the present study, all power parameters
estimated were approximately 1.8 (data not shown) which indi-
cated that the distributions were valid.
On the other hand, the present study has several limitations.
First, the deﬁnition of abdominal obesity did not refer to the
National Cholesterol Education Program Expert Panel on Detec-
tion, Evaluation, and Treatment of High Blood Cholesterol in
Adults III criteria.19 However, the Japanese criteria of waist
T. Sairenchi et al. / Journal of Epidemiology 27 (2017) 354e359 359circumference16 have been adopted on a nationwide scale in
Japan. For instance, the Japanese Society of Hypertension Guide-
lines for the Management of Hypertension adopted the Japanese
waist circumference criteria (85 cm for men and 90 cm for
women) as deﬁning abdominal obesity. According to the National
Health and Nutrition Survey in Japan, 2013,25 conducted by the
Ministry of Health, Labour and Welfare, Japan, the prevalence of
high waist circumference (85 cm for men and 90 cm for
women) was 34% among a representative sample of the Japanese
population aged 20 years or older. Second, further studies are
warranted to ascertain the generalizability of the ﬁndings due to
the low participation rate (34%) in health-checkups in the study
area and the low proportion of study subjects among participants
in health-checkups.
In summary, hypertension, independent of abdominal obesity,
appears to impose the greatest burden among the obesity-related
cardiovascular risk factors on Japanese National Health Insurance
expenditures.Conﬂict of interest
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